Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug;9(8):4473-4475.
doi: 10.21037/tcr-2020-004.

Vaccines against glioblastoma: reflections on the ICT-107 phase IIb trial

Steven De Vleeschouwer  1   2   3
Affiliations
Editorial

Vaccines against glioblastoma: reflections on the ICT-107 phase IIb trial

Steven De Vleeschouwer. Transl Cancer Res. 2020 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure from (available at http://dx.doi.org/10.21037/tcr-2020-004). Dr. SDV reports a patent 16805742.0-1109 licensed to Ovensa Inc. and SDV is member of the Data Safety Monitoring Committee of the Gliovax trial, Germany. SDV organizes Gliolan training sessions (Medac GmbH) in Belgium for which a fee is paid. SDV has performed consultancy work for Lamepro, distributing Gliolan in Belgium and the Netherlands.

Comment on

References

    1. Yu JS, Wheeler CJ, Zeltzer PM, et al. Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res 2001;61:842-7. - PubMed
    1. Bregy A, Wong TM, Shah AH, et al. Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme. Cancer Treat Rev 2013;39:891-907. 10.1016/j.ctrv.2013.05.007 - DOI - PubMed
    1. Cao JX, Zhang XY, Liu JL, et al. Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis. PLoS One 2014;9:e107173. 10.1371/journal.pone.0107173 - DOI - PMC - PubMed
    1. Wen PY, Reardon DA, Armstrong TS, et al. A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma. Clin Cancer Res 2019;25:5799-807. 10.1158/1078-0432.CCR-19-0261 - DOI - PMC - PubMed
    1. Liau LM, Ashkan K, Tran DD, et al. First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. J Transl Med 2018;16:142. 10.1186/s12967-018-1507-6 - DOI - PMC - PubMed